They measured the levels of the cellular prion protein (PrPC) in plasma samples from PD patients with or without cognitive impairments, since this protein has been linked to cognitive decline typical of NDs, such as Alzheimer’s disease (AD) and PD [147]. The gene discussed is PRNP; the disease is early-onset autosomal dominant Alzheimer disease.